☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
HER-2 positive
AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) Receive the FDA's Accelerated Approval for HER-2 Positive Unrese...
December 26, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.